{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:02:55Z","timestamp":1774350175211,"version":"3.50.1"},"reference-count":30,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Postattenuation neurologic signs (PANS) are serious complications following surgical ligation of congenital portosystemic shunts (cPSS) in dogs, but their pathogenesis remains incompletely understood. We hypothesized that surgical ligation alters hepatic tryptophan metabolism through increased substrate delivery and inflammation, leading to changes in kynurenine pathway metabolites that may contribute to PANS. Ten dogs diagnosed with cPSS between April 2019 and December 2023 underwent surgical ligation. Serum samples were collected preoperatively and on postoperative days 1, 2, and 3. Serum concentrations of quinolinic acid (QA) and 3-hydroxykynurenine (3OHKYN) were measured using ELISA in this retrospective observational study. Dogs exhibiting neurological signs within 3 days postoperatively were classified as having PANS. Serum QA concentrations showed no significant postoperative changes and did not differ between dogs with and without PANS. In contrast, serum 3OHKYN concentrations decreased significantly after surgery (p = 0.002). Dogs that developed PANS had significantly lower serum 3OHKYN concentrations on postoperative day 1 (p = 0.048) and exhibited greater reductions from baseline on postoperative days 1 and 3 (p = 0.024 and 0.017, respectively). These preliminary findings suggest that postoperative reductions in 3OHKYN, rather than increases in QA, are associated with PANS development, indicating that altered tryptophan metabolism may play a role in its pathogenesis and warrant further investigation in larger studies.<\/jats:p>","DOI":"10.3390\/vetsci13040308","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:02:49Z","timestamp":1774339369000},"page":"308","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative Serum Quinolinic Acid and 3-Hydroxykynurenine in Dogs with Congenital Portosystemic Shunt: A Pilot Study of Their Association with Postattenuation Neurologic Signs"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2973-8848","authenticated-orcid":false,"given":"Shoma","family":"Mikawa","sequence":"first","affiliation":[{"name":"Faculty of Veterinary Medicine, Okayama University of Science, Imabari 794-8555, Ehime, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Ishimaru","sequence":"additional","affiliation":[{"name":"Seiwadai Animal Hospital, Kawanishi 666-0142, Hyogo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Okamura","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine, Okayama University of Science, Imabari 794-8555, Ehime, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/vr.142.14.358","article-title":"Surgical treatment of intrahepatic portosystemic shunts in 45 dogs","volume":"142","author":"White","year":"1998","journal-title":"Vet. Rec."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Konstantinidis, A.O., Patsikas, M.N., Papazoglou, L.G., and Adamama-Moraitou, K.K. (2023). Congenital Portosystemic Shunts in Dogs and Cats: Classification, Pathophysiology, Clinical Presentation and Diagnosis. Vet. Sci., 10.","DOI":"10.3390\/vetsci10020160"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1292\/jvms.18-0442","article-title":"Feasibility of complete surgical ligation on 72 dogs with singular extrahepatic congenital portosystemic shunt based on portal pressure and comparison of intraoperative mesenteric portovenography","volume":"81","author":"Kayanuma","year":"2019","journal-title":"J. Vet. Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Konstantinidis, A.O., Adamama-Moraitou, K.K., Patsikas, M.N., and Papazoglou, L.G. (2023). Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis. Vet. Sci., 10.","DOI":"10.3390\/vetsci10050346"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/vsu.13729","article-title":"Postattenuation neurologic signs after surgical attenuation of congenital portosystemic shunts in dogs: A review","volume":"51","author":"Mullins","year":"2022","journal-title":"Vet. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1532-950X.1997.tb01483.x","article-title":"Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts","volume":"26","author":"Aronson","year":"1997","journal-title":"Vet. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.14336\/AD.2022.0916","article-title":"Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies","volume":"14","author":"Huang","year":"2023","journal-title":"Aging Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Teunis, C., Nieuwdorp, M., and Hanssen, N. (2022). Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases. Metabolites, 12.","DOI":"10.3390\/metabo12060514"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IJTR.S2097","article-title":"Kynurenine pathway metabolites in humans: Disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, Y., Zhang, Y., Wang, W., Zhang, Y., Dong, X., and Liu, Y. (2025). Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease. Metabolites, 15.","DOI":"10.3390\/metabo15030210"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbw221","article-title":"Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis","volume":"43","author":"Plitman","year":"2017","journal-title":"Schizophr. Bull."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: A systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","article-title":"Kynurenine and its metabolites in Alzheimer\u2019s disease patients","volume":"55","author":"Gulaj","year":"2010","journal-title":"Adv. Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100270","DOI":"10.1016\/j.ensci.2020.100270","article-title":"Kynurenine pathway in Parkinson\u2019s disease-An update","volume":"21","author":"Venkatesan","year":"2020","journal-title":"eNeurologicalSci"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF01262727","article-title":"Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice","volume":"42","author":"Lapin","year":"1978","journal-title":"J. Neural Transm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jnr.24980","article-title":"Increased susceptibility to quinolinic acid-induced seizures and long-term changes in brain oscillations in an animal model of glutaric acidemia type I","volume":"100","author":"Pasquetti","year":"2022","journal-title":"J. Neurosci. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0887-8994(94)90060-4","article-title":"Kynurenic acid is decreased in cerebrospinal fluid of patients with infantile spasms","volume":"10","author":"Yamamoto","year":"1994","journal-title":"Pediatr. Neurol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, S., Gilot, D., Ahn, S.B., Lam, V., Shin, J.S., Guillemin, G.J., and Heng, B. (2021). Involvement of Kynurenine Pathway in Hepatocellular Carcinoma. Cancers, 13.","DOI":"10.3390\/cancers13205180"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2460\/ajvr.2002.63.1167","article-title":"Cerebrospinal fluid glutamine, tryptophan, and tryptophan metabolite concentrations in dogs with portosystemic shunts","volume":"63","author":"Holt","year":"2002","journal-title":"Am. J. Vet. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: Tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/jvim.16135","article-title":"Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation","volume":"35","author":"Devriendt","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone. Marrow Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","article-title":"Blood-brain barrier transport of kynurenines: Implications for brain synthesis and metabolism","volume":"56","author":"Fukui","year":"1991","journal-title":"J. Neurochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5582\/bst.2022.01352","article-title":"Can kynurenine pathway be considered as a next-generation therapeutic target for Parkinson\u2019s disease? An update information","volume":"16","author":"Qin","year":"2022","journal-title":"Biosci. Trends"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/jnc.16099","article-title":"Xanthurenic acid: A role in brain intercellular signaling","volume":"168","author":"Maitre","year":"2024","journal-title":"J. Neurochem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Roth, W., Zadeh, K., Vekariya, R., Ge, Y., and Mohamadzadeh, M. (2021). Tryptophan Metabolism and Gut-Brain Homeostasis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062973"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/j.1471-4159.1987.tb02455.x","article-title":"Increased concentrations of 3-hydroxykynurenine in vitamin B6 deficient neonatal rat brain","volume":"49","author":"Guilarte","year":"1987","journal-title":"J. Neurochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"110385","DOI":"10.1016\/j.yebeh.2025.110385","article-title":"MK-212 precipitates seizure-induced death in amygdala-kindled mice via a non-5-HT2C receptor-mediated mechanism","volume":"167","author":"Joyal","year":"2025","journal-title":"Epilepsy Behav."}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/4\/308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:45:37Z","timestamp":1774341937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/13\/4\/308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["vetsci13040308"],"URL":"https:\/\/doi.org\/10.3390\/vetsci13040308","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}